Fybogel Mebeverine - 10 sachets ( Expiry date - 04/2025)

NOTE : This product is on short expiry date (04/2025)

Fybogel Mebeverine can be used to relieve the symptoms associated with irritable bowel syndrome (IBS) including painful spasms, constipation and bloating. It does this by using two active ingredients: ispaghula husk, and mebeverine.

To help restore bowel regularity, Fybogel Mebeverine should be taken twice a day, one sachet in the morning and one sachet in the evening. These sachets are manufactured by Forum Health Products and are suitable for adults and children over the age of 12 years.

Usage Instructions

Fybogel Mebeverine sachets should not be consumed without water. Each individual dose should be stirred and dissolved fully in water before use. Without water, there is a risk that the contents of the sachet may cause a blockage within the gut. Always make sure to drink plenty of fluids throughout the day.

For adults and children over the age of 12: Mix 1 sachet of Fybogel Mebeverine with 150ml of water half an hour before breakfast and half an hour before dinner and drink immediately. If necessary, a third dose can be taken around lunchtime.

Warnings

You should contact your doctor before beginning to use Fybogel Mebeverine if any of the following apply to you:

You are 40 years of age or over
You have lost your appetite or lost weight
You have blood in your stools
You are vomiting
You are looking pale and feeling tired
You have severe constipation
You have a fever
You have recently traveled abroad
You are pregnant, or planning to become pregnant
You have unusual bleeding or discharge from your vagina
You have difficulty or pain when urinating
You have been prescribed a potassium-sparing diuretic medicine
You have been prescribed potassium supplements
After taking Fybogel mebeverine sachets you may experience an increase in flatulence and bloating. This is because of the excess gas that will be present in the stomach and intestines in the first few days, however, this will improve over time.

https://www.medicines.org.uk/emc/files/pil.1447.pdf